MENLO PARK, Calif.--(BUSINESS WIRE)--May is Stroke Awareness Month and in commemoration, iSchemaView, the worldwide leader in advanced imaging for stroke, is releasing its first market intelligence data from RAPID. The RAPID platform is designed to provide physicians with fast, fully automated, and easy-to-interpret imaging that facilitates clinical decision-making around stroke. Stroke afflicts around 800,000 Americans each year and ranks as the number five cause of death and number one cause of disability in the United States. New RAPID data reveals that over 40,000 more patients’ lives were impacted in 2018 over 2017 via this advanced technology, more than doubling the number of patients scanned and thrombectomies indicated by imaging.
iSchemaView’s RAPID has changed how physicians approach stroke care. From 2017 to 2018 there was over a 100% increase in patients imaged with RAPID worldwide (41,125 in 2017 and 82,365 in 2018). Perfusion imaging criteria was met for thrombectomy in 12,285 patients in 2017 and 25,269 in 2018. Based on the first quarter of 2019, RAPID is on pace to image over 132,500 patients in 2019 and identify over 40,000 potential patients for thrombectomies. The platform is also estimated to process over 250,000 total scans this year.
While the above represents dramatic overall growth in patients addressed and thrombectomies indicated around the world, there was also significant same-site growth. Looking only at care sites active with the RAPID platform in 2017 as compared to the same sites in 2018, there was over a 50% growth in patients addressed (39,955 in 2017 and 60,821 in 2018), and potential thrombectomies indicated (11,811 in 2017 and 17,742 in 2018).
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
This dramatic expansion in patients scanned tracks with new 2018 American Heart Association and American Stroke Association guidelines that have dramatically altered the management of acute stroke. These new guidelines were established after a series of studies were conducted and published by iSchemaView co-founder, Dr. Greg Albers and others.
“RAPID has greatly impacted our ability to offer life- and disability-saving care to our patients,” said Cherylee Chang, M.D., medical director, Neuroscience Institute/Neurocritical Care at The Queen's Medical Center. “In 2017 we performed 37 thrombectomies; this increased to 93 in 2018 and we have already exceeded 30 cases in the first 3 months of 2019. Due to the ability of our stroke team, which includes our neurointerventionalists, to receive immediate results of RAPID’s perfusion imaging, our median door-to-puncture time is 46 minutes. RAPID has revolutionized stroke care.”